J. Makhema

B. Wylie, R. Shapiro, R. Luckett, 2021, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Viral Reservoir in Early-Treated HIV-Infected Children and Markers for Sustained Viral Suppression.

M. Hughes, D. Kuritzkes, M. Lichterfeld, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial

J. Gallant, Myron S. Cohen, K. Mayer, 2016, Journal of acquired immune deficiency syndromes.

Fetal biometry following in utero exposure to dolutegravir- or efavirenz-based antiretroviral therapy.

L. Yee, J. Makhema, K. Powis, 2020, AIDS.

Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy.

M. Hughes, S. Lockman, D. Kitch, 2011, The Journal of infectious diseases.

Prevalence and Determinants of Hypertension Awareness, Treatment, and Control in Botswana: A Nationally Representative Population-Based Survey

S. Lockman, David J. Hunter, T. Masupe, 2020, International journal of hypertension.

Prevalence and Determinants of Hypertension Awareness, Treatment, and Control in Botswana: ANationally Representative Population-Based Survey

D. Hunter, S. Lockman, T. Masupe, 2020 .

Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.

Ingrid A. Beck, J. Baeten, A. Wald, 2011, The Journal of infectious diseases.

Detection of inducible replication-competent HIV-1C provirus despite long-term antiretroviral treatment in perinatally infected adolescents in Botswana.

S. Lockman, S. Gaseitsiwe, M. Essex, 2020, AIDS research and human retroviruses.

Sikhulile Moyo, Victor DeGruttola, Lauren E. Buck, 2013, PloS one.

Plasma Cytokine Levels in Chronic Asymptomatic HIV-1 Subtype C Infection as an Indicator of Disease Progression in Botswana : A Retrospective Case Control Study

R. Mitchell, S. Gaseitsiwe, M. Essex, 2015 .

Eff ects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection : results from the phase 3 HPTN 052 randomised controlled trial

D. Havlir, J. Gallant, S. Swindells, 2014 .

Reassuring Birth Outcomes With Tenofovir/Emtricitabine/Efavirenz Used for Prevention of Mother-to-Child Transmission of HIV in Botswana

S. Lockman, S. Dryden-Peterson, M. Essex, 2016, Journal of acquired immune deficiency syndromes.

R. Shapiro, J. Makhema, K. Powis, 2017, International journal of STD & AIDS.

Mother-to-Child HIV Transmission with in utero Dolutegravir vs. Efavirenz in Botswana.

M. Hughes, D. Kuritzkes, M. Lichterfeld, 2020, Journal of acquired immune deficiency syndromes.

Brief Report: High Sensitivity and Specificity of the Cepheid Xpert HIV-1 Qualitative Point-of-Care Test Among Newborns in Botswana

R. Gelman, S. Lockman, S. Gaseitsiwe, 2017, Journal of acquired immune deficiency syndromes.

Antiretroviral Treatment Initiation Among HIV-Infected Pregnant Women with Low CD4+ Cell Counts in Gaborone, Botswana

S. Lockman, S. Dryden-Peterson, M. Essex, 2009, Journal of acquired immune deficiency syndromes.

In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm

J. Blackard, S. Gaseitsiwe, M. Essex, 2018, Genes.

High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana

J. Blackard, Ivayla E. Gyurova, S. Gaseitsiwe, 2017, Open forum infectious diseases.

Cross‐sectional trends in HIV prevalence among pregnant women in Botswana: an opportunity for PrEP?

S. Lockman, C. Morroni, R. Shapiro, 2022, Journal of the International AIDS Society.

Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV‐infected women in Botswana

Iain J. MacLeod, S. Lockman, M. Essex, 2011, Journal of medical virology.

Higher-Than-Expected Rates of Lactic Acidosis Among Highly Active Antiretroviral Therapy-Treated Women in Botswana: Preliminary Results from a Large Randomized Clinical Trial

D. Kuritzkes, V. DeGruttola, M. Essex, 2007, Journal of acquired immune deficiency syndromes.

Decreased diarrheal and respiratory disease in HIV exposed uninfected children following vaccination with rotavirus and pneumococcal conjugate vaccines

M. Hughes, S. Lockman, R. Shapiro, 2020, PloS one.

Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana

D. Bangsberg, D. Dickinson, I. Thior, 2006, AIDS care.

Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile

D. Kuritzkes, Xu G. Yu, M. Lichterfeld, 2019, Science Translational Medicine.

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

J. Mullins, J. Baeten, S. Kapiga, 2010, The New England journal of medicine.

Detecting congenital malformations - Lessons learned from the Mpepu study, Botswana

S. Lockman, L. Holmes, R. Shapiro, 2017, PloS one.

Linear Growth Faltering Among HIV-Exposed Uninfected Children

W. Fawzi, C. Sudfeld, Quanhong Lei, 2016, Journal of acquired immune deficiency syndromes.

Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.

Peter B Gilbert, Max Essex, Lisa Stevens, 2006, JAMA.

Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana

J. Blackard, S. Gaseitsiwe, M. Essex, 2016, Open forum infectious diseases.

Comparison of Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Participants Enrolled in a Multinational Clinical Trial: HPTN 052

C. Thio, M. Hosseinipour, B. Grinsztejn, 2017, Journal of acquired immune deficiency syndromes.

Antiretroviral regimens in pregnancy and breast-feeding in Botswana.

M. Hughes, A. Act, S. Lockman, 2010, The New England journal of medicine.

Increased Risk of Severe Infant Anemia After Exposure to Maternal HAART, Botswana

M. Hughes, S. Lockman, S. Dryden-Peterson, 2011, Journal of acquired immune deficiency syndromes.

Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana

J. Blackard, S. Gaseitsiwe, M. Essex, 2015, BMC Infectious Diseases.

High Prevalence of Hepatitis B Virus Infection Among People With HIV in Rural and Periurban Communities in Botswana

S. Lockman, S. Gaseitsiwe, M. Essex, 2023, Open forum infectious diseases.

Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and AIDS in Botswana

Max Essex, P. Gilbert, D. Bangsberg, 2003, Journal of acquired immune deficiency syndromes.

No Clinically Significant Drug-Resistance Mutations in HIV-1 Subtype C–Infected Women After Discontinuation of NRTI-Based or PI-Based HAART for PMTCT in Botswana

S. Lockman, S. Gaseitsiwe, M. Essex, 2013, Journal of acquired immune deficiency syndromes.

Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana

S. Lagakos, T. Ndung’u, P. Gilbert, 2006, AIDS.

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

S. Delany-Moretlwe, J. Hughes, B. G. Mirembe, 2022, The Lancet.

Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana.

M. Wainberg, S. Gaseitsiwe, I. Kasvosve, 2018, AIDS research and human retroviruses.

Unintended pregnancy, contraceptive use, and childbearing desires among HIV-infected and HIV-uninfected women in Botswana: across-sectional study

S. Lockman, K. Wirth, C. Morroni, 2015, BMC Public Health.

Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception.

R. Shapiro, J. Makhema, Rebecca Zash, 2018, The New England journal of medicine.

Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana

V. DeGruttola, M. Essex, V. Novitsky, 2010, AIDS.

Therapeutic Levels of Lopinavir in Late Pregnancy and Abacavir Passage into Breast Milk in the Mma Bana Study, Botswana

S. Lockman, E. Capparelli, M. Essex, 2013, Antiviral therapy.

Temporal reduction of HIV type 1 viral load in breast milk by single-dose nevirapine during prevention of MTCT.

T. Ndung’u, S. Lockman, I. Thior, 2009, AIDS research and human retroviruses.

Pregnancy Rates and Birth Outcomes Among Women on Efavirenz-Containing Highly Active Antiretroviral Therapy in Botswana

M. Essex, R. Marlink, J. Makhema, 2007, Journal of acquired immune deficiency syndromes.

Validation of A Point-of-Care Lactate Device For Screening At-Risk Adults Receiving Combination Antiretroviral Therapy In Botswana.

M. Mine, M. Essex, V. Novitsky, 2011, Journal of antivirals & antiretrovirals.

Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

S. Lockman, H. Ribaudo, S. Dryden-Peterson, 2012, The Journal of infectious diseases.

High Prevalence of Hypertension and Placental Insufficiency, but No In Utero HIV Transmission, among Women on HAART with Stillbirths in Botswana

D. Roberts, S. Lockman, M. Essex, 2012, PloS one.

Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana.

E. T. Tchetgen Tchetgen, S. Lockman, V. DeGruttola, 2019, The New England journal of medicine.

Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey.

S. Lockman, V. DeGruttola, M. Essex, 2016, The lancet. HIV.

Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial

J. Baeten, S. Kapiga, H. Rees, 2010, The Lancet.

Daily Acyclovir Delays HIV-1 Disease Progression Among HIV-1/HSV-2 Dually-Infected Persons: A Randomized Trial

J. Baeten, S. Kapiga, H. Rees, 2010 .

The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana

J. Blackard, S. Gaseitsiwe, M. Essex, 2017, Open forum infectious diseases.

Evolutionary gamut of in vivo Gag substitutions during early HIV-1 subtype C infection.

L. Margolin, Rui Wang, M. Essex, 2011, Virology.

Timing Constraints of In Vivo Gag Mutations during Primary HIV-1 Subtype C Infection

S. Lagakos, L. Margolin, Rui Wang, 2009, PloS one.

Prognostic Value of HIV-1 RNA on CD4 Trajectories and Disease Progression Among Antiretroviral-Naive HIV-Infected Adults in Botswana: A Joint Modeling Analysis.

T. Moeti, Rui Wang, M. Essex, 2016, AIDS research and human retroviruses.

Extended high viremics: a substantial fraction of individuals maintain high plasma viral RNA levels after acute HIV-1 subtype C infection

Victor De Gruttola, Vladimir Novitsky, Thumbi Ndung'u, 2011, AIDS.

HIV-1 Subtype C-Infected Individuals Maintaining High Viral Load as Potential Targets for the “Test-and-Treat” Approach to Reduce HIV Transmission

Sikhulile Moyo, Victor DeGruttola, Shahin Lockman, 2010, PloS one.

Viral Load and CD4+ T-Cell Dynamics in Primary HIV-1 Subtype C Infection

S. Lagakos, M. Finucane, M. Essex, 2009, Journal of acquired immune deficiency syndromes.

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

Lindsay N. Carpp, Allan C. deCamp, J. Mullins, 2022, Nature Medicine.

Immunohaematological reference values for HIV-negative healthy adults in Botswana

M. Mine, I. Mtoni, M. Essex, 2011, African journal of laboratory medicine.

Evolution of proviral gp120 over the first year of HIV-1 subtype C infection.

Sikhulile Moyo, Caitlin Bonney, Lauren Margolin, 2009, Virology.

Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype C.

Sikhulile Moyo, Daniel R Kuritzkes, Shahin Lockman, 2012, Virology.

Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ART.

Iain J. MacLeod, S. Lockman, I. Thior, 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Short Communication: Low False Recent Rate of Limiting Antigen-Avidity Assay Combined with HIV-1 RNA Data in Botswana.

S. Gaseitsiwe, M. Essex, V. Novitsky, 2016, AIDS research and human retroviruses.

Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052

M. Hosseinipour, S. Chariyalertsak, B. Grinsztejn, 2017, PloS one.

Long-term clinical, immunologic, and virologic outcomes among early-treated children with HIV in Botswana: a nonrandomized controlled clinical trial.

M. Hughes, D. Kuritzkes, M. Lichterfeld, 2022, Journal of acquired immune deficiency syndromes.

Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life

M. Hughes, D. Kuritzkes, M. Lichterfeld, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-exposed children account for more than half of 24-month mortality in Botswana

S. Lockman, H. Ribaudo, M. Essex, 2016, BMC Pediatrics.

Strengthening Healthcare Capacity Through a Responsive, Country-Specific, Training Standard: The KITSO AIDS Training Program’s Sup-port of Botswana’s National Antiretroviral Therapy Rollout

M. Mine, R. Marlink, D. Baxter, 2008, The open AIDS journal.

HIV diagnostic algorithm requires confirmatory testing for initial indeterminate or positive screens in the first week of life.

M. Hughes, D. Kuritzkes, M. Lichterfeld, 2020, AIDS.

Undetectable proviral deoxyribonucleic acid in an adolescent perinatally infected with human immunodeficiency virus-1C and on long-term antiretroviral therapy resulted in viral rebound following antiretroviral therapy termination

T. de Oliveira, S. Lockman, S. Gaseitsiwe, 2019, Medicine.

Immune correlates of HIV-1 reservoir cell decline in early-treated infants

D. Kuritzkes, Xu G. Yu, M. Lichterfeld, 2022, Cell reports.

HIV in the workplace in Botswana: incidence, prevalence, and disease severity.

T. Sterling, E. Riviello, B. Shepherd, 2007, AIDS research and human retroviruses.

Association of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection With Maternal Mortality and Neonatal Birth Outcomes in Botswana by Human Immunodeficiency Virus Status

S. Lockman, S. Moyo, R. Shapiro, 2022, Obstetrics and gynecology.

Are morbidity and mortality estimates from randomized controlled trials externally valid? A comparison of outcomes among infants enrolled into an RCT or a cohort study in Botswana

S. Lockman, R. Shapiro, J. Makhema, 2021, BMC Medical Research Methodology.

Factors Associated with Infant Feeding Choices Among Women with HIV in Botswana

S. Lockman, H. Taddese, R. Shapiro, 2021, Maternal and Child Health Journal.

Incident HIV acquisition among pregnant women in Botswana: findings from the Tsepamo birth outcomes surveillance study

S. Lockman, C. Morroni, R. Shapiro, 2023, Journal of the International AIDS Society.

Safety and Pharmacokinetics of Intravenous 10-1074 and VRC01LS in Young Children

M. Hughes, D. Kuritzkes, M. Lichterfeld, 2022, Journal of acquired immune deficiency syndromes.

Reaching 90-90-90 in Botswana.

S. Lockman, M. Essex, M. Essex, 2019, Current opinion in HIV and AIDS.

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.

Kenneth H Mayer, Ian Sanne, Max Essex, 2014, The Lancet. Infectious diseases.

Undisclosed antiretroviral drug use in Botswana: implication for national estimates

S. Lockman, K. Wirth, W. Clarke, 2018, AIDS.

Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052).

K. Mayer, C. Hendrix, I. Sanne, 2013, The Journal of infectious diseases.

Point-of-Care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities Is Feasible and Reliable

Sikhulile Moyo, Melanie Prague, Max Essex, 2016, Journal of Clinical Microbiology.

Lack of Virological Suppression Among Young HIV-Positive Adults in Botswana

S. Lockman, M. Essex, E. Tchetgen, 2018, Journal of acquired immune deficiency syndromes.

Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana

S. Lockman, S. W. Mpoloka, E. Bile, 2022, Journal of global antimicrobial resistance.

Prevalence and Clinical Associations of CXCR4-Using HIV-1 Among Treatment-Naive Subtype C-Infected Women in Botswana

D. Kuritzkes, S. Lockman, M. Essex, 2011, Journal of acquired immune deficiency syndromes.

The aetiology of diarrhoea, pneumonia and respiratory colonization of HIV-exposed infants randomized to breast- or formula-feeding

S. Lockman, I. Thior, A. McAdam, 2016, Paediatrics and international child health.

Increased Risk of Preterm Delivery Among HIV-Infected Women Randomized to Protease Versus Nucleoside Reverse Transcriptase Inhibitor–Based HAART During Pregnancy

M. Hughes, S. Lockman, D. Kitch, 2011 .

Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana.

S. Lockman, D. Jacobson, M. Essex, 2019, The New England journal of medicine.

HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana

M. Hughes, S. Lockman, D. Kitch, 2013, AIDS.

Prediction of Coreceptor Tropism in HIV-1 Subtype C in Botswana

S. Lockman, S. Gaseitsiwe, M. Essex, 2023, Viruses.

Risk factors for very preterm delivery and delivery of very‐small‐for‐gestational‐age infants among HIV‐exposed and HIV‐unexposed infants in Botswana

H. Ribaudo, M. Essex, R. Shapiro, 2011, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Weight gain during pregnancy among women initiating dolutegravir in Botswana

C. Zera, S. Lockman, B. Wylie, 2020, EClinicalMedicine.

In Utero Efavirenz Exposure and Neurodevelopmental Outcomes in HIV-exposed Uninfected Children in Botswana.

Paige L. Williams, S. Lockman, P. Williams, 2019, The Pediatric infectious disease journal.

Mid-trimester cervical length not associated with HIV status among pregnant women in Botswana

B. Wylie, R. Shapiro, J. Makhema, 2020, PloS one.

High HIV-1 RNA Among Newly Diagnosed People in Botswana.

S. Lockman, V. De Gruttola, M. Prague, 2017, AIDS research and human retroviruses.

Maternal biomarkers of endothelial dysfunction and pregnancy outcomes in women with and without HIV in Botswana

S. Lockman, S. Moyo, G. Masheto, 2023, PloS one.

Self-reported risky sexual practices among adolescents and young adults in Botswana

S. Lockman, K. Wirth, S. Dryden-Peterson, 2019, Southern African journal of HIV medicine.

Acceptability of oral HIV self-testing among female sex workers in Gaborone, Botswana

T. Bärnighausen, S. Lockman, L. Bogart, 2020, PloS one.

Increasing knowledge of HIV status in a country with high HIV testing coverage: Results from the Botswana Combination Prevention Project

S. Lockman, E. Bile, K. Wirth, 2019, PloS one.

CD101 genetic variants modify regulatory and conventional T cell phenotypes and functions

Corinne M. Mar, J. Mullins, J. Baeten, 2021, Cell reports. Medicine.

Prevalence, Magnitude, and Correlates of HIV-1 Genital Shedding in Women on Antiretroviral Therapy

James P. Hughes, J. Mullins, J. Baeten, 2017, The Journal of infectious diseases.

HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads

S. Gaseitsiwe, M. Essex, V. Novitsky, 2022, Infection and drug resistance.

Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial – BCPP/Ya Tsie trial

Lerato E. Magosi, M. Lipsitch, C. Fraser, 2022, eLife.

Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial – BCPP/ Ya Tsie trial

Lerato E. Magosi, M. Lipsitch, C. Fraser, 2021 .

Establishing and Delivering Quality Radiation Therapy in Resource-Constrained Settings: The Story of Botswana.

D. Gierga, J. Efstathiou, S. Dryden-Peterson, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in Botswana

T. Phindela, S. Moyo, A. Izu, 2023, Journal of Infection.

Identification of primary HIV-1C infection in Botswana

M. Essex, G. Seage, M. Essex, 2008, AIDS care.

Predictors of early breastfeeding cessation among HIV‐infected women in Botswana

S. Lockman, M. Essex, S. Moyo, 2016, Tropical medicine & international health : TM & IH.

Cabotegravir for Prevention of HIV-1 in Women: Results From HPTN 084, a Phase III, Randomised Controlled Trial

S. Delany-Moretlwe, J. Hughes, M. Moorhouse, 2022, SSRN Electronic Journal.

HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052

J. Gallant, J. Eron, M. Hosseinipour, 2017, Journal of acquired immune deficiency syndromes.

M. Hughes, S. Lockman, K. Mcintosh, 2018, Southern African journal of HIV medicine.

Advanced HIV disease in the botswana combination prevention project: prevalence, risk factors, and outcomes.

S. Lockman, J. Jarvis, T. Marukutira, 2020, AIDS.

Abacavir alters the transcription of inflammatory cytokines in virologically suppressed, HIV-infected women

Iain J. MacLeod, S. Lockman, M. Essex, 2012, Journal of the International AIDS Society.

Small babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change and improve counting

Julie M. Herlihy, R. Noor, W. Fawzi, 2023, The Lancet.

Health impact and cost-effectiveness of HIV testing, linkage, and early antiretroviral treatment in the Botswana Combination Prevention Project

S. Resch, E. Hyle, K. Freedberg, 2022, Journal of Acquired Immune Deficiency Syndromes.

Effects of in Utero Antiretroviral Exposure on Longitudinal Growth of HIV-Exposed Uninfected Infants in Botswana

S. Lockman, L. Smeaton, S. Dryden-Peterson, 2011, Journal of acquired immune deficiency syndromes.

Near‐complete genome of SARS‐CoV‐2 Delta variant of concern identified in a symptomatic dog (Canis lupus familiaris) in Botswana

S. Lockman, S. Gaseitsiwe, S. Moyo, 2023, Veterinary medicine and science.

In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana

Paige L. Williams, S. Lockman, P. Williams, 2018, AIDS.

Predictors of Hypertension Among HIV Infected Adults in Botswana, Africa

R. Marlink, A. Campa, M. Baum, 2009 .

A seronegative case of HIV-1 subtype C infection in Botswana.

M. Essex, V. Novitsky, E. Woldegabriel, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Barriers and facilitators to linkage to care and ART initiation in the setting of high ART coverage in Botswana

S. Lockman, P. Bachanas, R. Lebelonyane, 2020, AIDS care.

Mapping of HIV-1C Transmission Networks Reveals Extensive Spread of Viral Lineages across Villages in Botswana Treatment-as-Prevention Trial.

S. Lockman, V. DeGruttola, K. Wirth, 2020, The Journal of infectious diseases.

Estimated age and gender profile of individuals missed by a home-based HIV testing and counselling campaign in a Botswana community

S. Lockman, V. DeGruttola, Quanhong Lei, 2015, Journal of the International AIDS Society.

Emulating a Sequence of 13 Target Trials of Antibiotic Initiation During Each Week from 24 Weeks Through 36 Weeks Gestation

S. Hernández-Díaz, S. Mumford, S. Lockman, 2023 .

High rates of adverse birth outcomes in HIV and syphilis co-infected women in Botswana.

S. Lockman, S. Moyo, R. Shapiro, 2019, Journal of acquired immune deficiency syndromes.

Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana.

M. Essex, R. Marlink, S. Moyo, 2016, The British journal of nutrition.

Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015

E. T. Tchetgen Tchetgen, S. Lockman, M. Mine, 2018, PloS one.

Population uptake of HIV testing, treatment, viral suppression, and male circumcision in Botswana: a cluster-randomized trial

S. Lockman, V. DeGruttola, K. Wirth, 2021 .

A Randomized Trial of Mogen Clamp Versus Plastibell for Neonatal Male Circumcision in Botswana

S. Lockman, K. Wirth, R. Shapiro, 2013, Journal of acquired immune deficiency syndromes.

In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana

M. Hughes, W. Fawzi, S. Lockman, 2016, AIDS.

Highly Active Antiretroviral Therapy Versus Zidovudine for Prevention of Mother-to-Child Transmission in a Programmatic Setting, Botswana

M. Hughes, S. Lockman, S. Dryden-Peterson, 2011, Journal of acquired immune deficiency syndromes.

Iron, folic acid, and multiple micronutrient supplementation strategies during pregnancy and adverse birth outcomes in Botswana

W. Fawzi, S. Lockman, C. Sudfeld, 2022, The Lancet. Global health.

Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana

D. Kuritzkes, M. Lichterfeld, S. Lockman, 2023, Science Translational Medicine.

Adverse Birth Outcomes in Botswana Among Women With Vertically or Horizontally Acquired Human Immunodeficiency Virus.

S. Lockman, G. Seage, R. Shapiro, 2020, Journal of the Pediatric Infectious Diseases Society.

The Impact of Syndromic Management of Vaginal Discharge Syndrome on Adverse Birth Outcomes in Botswana

S. Lockman, C. Morroni, R. Shapiro, 2021, Open Forum Infectious Diseases.

Impact of prophylactic antimalarials in pregnant women living with Human Immunodeficiency Virus on birth outcomes in Botswana

S. Lockman, R. Shapiro, J. Makhema, 2022, Tropical medicine & international health : TM & IH.

Atypical Hepatitis B Virus Serology Profile—Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative—In Hepatitis B Virus/HIV Coinfected Individuals in Botswana

S. Gaseitsiwe, S. Moyo, R. Musonda, 2023, Viruses.

Prevention of HIV-1 infection with early antiretroviral therapy

S. Swindells, I. Hoffman, D. Celentano, 2011, Journal of Family Planning and Reproductive Health Care.

Botswana should consider expansion of free antiretroviral therapy to immigrants

G. Seage, T. Marukutira, J. Makhema, 2019, Journal of the International AIDS Society.

Predicted broadly neutralizing antibody (bnAb) resistance and associated envelope characteristics of adults with HIV-1 seroconversion in Botswana

S. Lockman, S. Gaseitsiwe, S. Moyo, 2023, Research square.

Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples.

J. Baeten, S. Delany-Moretlwe, M. McElrath, 2015, The Journal of infectious diseases.

Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering

S. Gaseitsiwe, V. Novitsky, M. F. McLane, 2015, Journal of Clinical Microbiology.

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

James P. Hughes, J. Baeten, E. Bukusi, 2010, The New England journal of medicine.

Plasma Cytokine Levels in Chronic Asymptomatic HIV-1 Subtype C Infection as an Indicator of Disease Progression in Botswana: A Retrospective Case Control Study.

S. Gaseitsiwe, R. Marlink, S. Moyo, 2016, AIDS research and human retroviruses.

Linear Growth Faltering Among HIV-Exposed Uninfected Children

W. Fawzi, C. Sudfeld, Quanhong Lei, 2016, Journal of acquired immune deficiency syndromes.

HIV‐associated morbidity and mortality in a setting of high ART coverage: prospective surveillance results from a district hospital in Botswana

S. Lockman, N. Tapela, R. Shapiro, 2019, Journal of the International AIDS Society.

High Viral Load and Elevated Angiogenic Markers Associated With Increased Risk of Preeclampsia Among Women Initiating Highly Active Antiretroviral Therapy in Pregnancy in the Mma Bana Study, Botswana

M. Hughes, S. Lockman, T. McElrath, 2013, Journal of acquired immune deficiency syndromes.

Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception.

R. Shapiro, J. Makhema, Rebecca Zash, 2018, The New England journal of medicine.

Botswana should consider expansion of free antiretroviral therapy to immigrants

G. Seage, T. Marukutira, J. Makhema, 2019, Journal of the International AIDS Society.

Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana.

R. Marlink, S. Moyo, A. Campa, 2016, The British journal of nutrition.

Effect of Micronutrient Supplementation on Disease Progression in Asymptomatic, Antiretroviral-Naive, HIV-Infected Adults in Botswana

W. Fawzi, S. Lai, I. Thior, 2015 .

Pediatric Neurodevelopmental Functioning After In Utero Exposure to Triple-NRTI vs. Dual-NRTI + PI ART in a Randomized Trial, Botswana

Paige L. Williams, S. Lockman, S. Nichols, 2018, Journal of acquired immune deficiency syndromes.

Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy.

M. Hughes, S. Lockman, D. Kitch, 2011, The Journal of infectious diseases.

Lower insulin sensitivity in newborns with in utero HIV and antiretroviral exposure who are uninfected in Botswana.

M. Gerschenson, I. Kurland, M. Geffner, 2022, The Journal of infectious diseases.

Evaluation of Phylogenetic Methods for Inferring the Direction of Human Immunodeficiency Virus (HIV) Transmission: HIV Prevention Trials Network (HPTN) 052

C. Wymant, S. Chariyalertsak, B. Grinsztejn, 2021 .

Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana

S. Lockman, S. Gaseitsiwe, S. Moyo, 2023, Scientific reports.

Fostemsavir resistance-associated polymorphisms in HIV-1 subtype C in a large cohort of treatment-naïve and treatment-experienced individuals in Botswana

S. Lockman, S. Gaseitsiwe, V. Novitsky, 2023, Microbiology spectrum.

A Randomized Trial of Mogen Clamp Versus Plastibell for Neonatal Male Circumcision in Botswana

S. Lockman, K. Wirth, R. Shapiro, 2013, Journal of acquired immune deficiency syndromes.

Lower Insulin Sensitivity Through 36 Months of Life With in Utero HIV and Antiretroviral Exposure in Botswana: Results From the Tshilo Dikotla Study.

I. Kurland, S. Moyo, J. Makhema, 2024, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Counseling and Monitoring Approach for Supporting Breastfeeding Women Living With HIV in Botswana

E. Abrams, J. Makhema, K. Powis, 2021, Journal of acquired immune deficiency syndromes.